Literature DB >> 19210024

Depressive symptoms and the metabolic syndrome in childhood and adulthood: a prospective cohort study.

Laura Pulkki-Råback1, Marko Elovainio, Mika Kivimäki, Noora Mattsson, Olli T Raitakari, Sampsa Puttonen, Jukka Marniemi, Jorma S A Viikari, Liisa Keltikangas-Järvinen.   

Abstract

OBJECTIVE: To examine the reciprocal associations between depressive symptoms and clinical definitions of the metabolic syndrome in childhood and adulthood.
DESIGN: Population-based prospective cohort study of 921 participants (538 women and 383 men) in Finland. The components of the metabolic syndrome were measured in childhood (mean age 12 years) and again in adulthood (mean age 33 years). A revised version of the Beck Depression Inventory was used to assess depressive symptoms at the mean ages of 24 and 33. MAIN OUTCOME MEASURES: Metabolic syndrome defined by the National Cholesterol Education Program Adult Treatment Panel III (NCEP), the European Group for the Study of Insulin Resistance, and the International Diabetes Federation criteria.
RESULTS: In women, depressive symptoms were associated with increased risk of the metabolic syndrome in adulthood (odds ratio for NCEP metabolic syndrome per 1 SD increase in depressive symptoms 1.40, 95% confidence interval 1.05-1.85). The metabolic syndrome in childhood, in turn, predicted higher levels of depressive symptoms in adulthood (p = .03). In men, no associations were found between depressive symptoms and the clinical definitions of the metabolic syndrome.
CONCLUSION: The process linking depressive symptoms with the metabolic syndrome may go into both directions and may begin early in life. (c) 2009 APA, all rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19210024      PMCID: PMC3166561          DOI: 10.1037/a0012646

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  37 in total

1.  The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.

Authors:  Hanna-Maaria Lakka; David E Laaksonen; Timo A Lakka; Leo K Niskanen; Esko Kumpusalo; Jaakko Tuomilehto; Jukka T Salonen
Journal:  JAMA       Date:  2002-12-04       Impact factor: 56.272

2.  The relationship between psychological risk attributes and the metabolic syndrome in healthy women: antecedent or consequence?

Authors:  Katri Räikkönen; Karen A Matthews; Lewis H Kuller
Journal:  Metabolism       Date:  2002-12       Impact factor: 8.694

3.  Depressive symptomatology and coronary heart disease in Type I diabetes mellitus: a study of possible mechanisms.

Authors:  Leslie S Kinder; Thomas W Kamarck; Andrew Baum; Trevor J Orchard
Journal:  Health Psychol       Date:  2002-11       Impact factor: 4.267

Review 4.  Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms.

Authors:  Robert M Carney; Kenneth E Freedland; Gregory E Miller; Allan S Jaffe
Journal:  J Psychosom Res       Date:  2002-10       Impact factor: 3.006

5.  Depressive symptoms and lack of social integration in relation to prognosis of CHD in middle-aged women. The Stockholm Female Coronary Risk Study.

Authors:  M Horsten; M A Mittleman; S P Wamala; K Schenck-Gustafsson; K Orth-Gomér
Journal:  Eur Heart J       Date:  2000-07       Impact factor: 29.983

Review 6.  The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease.

Authors:  Steven M Haffner
Journal:  Am J Cardiol       Date:  2005-12-05       Impact factor: 2.778

7.  Hostility predicts metabolic syndrome risk factors in children and adolescents.

Authors:  Katri Räikkönen; Karen A Matthews; Kristen Salomon
Journal:  Health Psychol       Date:  2003-05       Impact factor: 4.267

8.  Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey.

Authors:  John K Ninomiya; Gilbert L'Italien; Michael H Criqui; Joanna L Whyte; Anthony Gamst; Roland S Chen
Journal:  Circulation       Date:  2003-12-15       Impact factor: 29.690

Review 9.  Association of depression with medical illness: does cortisol play a role?

Authors:  E Sherwood Brown; Femina P Varghese; Bruce S McEwen
Journal:  Biol Psychiatry       Date:  2004-01-01       Impact factor: 13.382

Review 10.  Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review.

Authors:  Lawson R Wulsin; Bonita M Singal
Journal:  Psychosom Med       Date:  2003 Mar-Apr       Impact factor: 4.312

View more
  46 in total

1.  Fasting Glucose and the Risk of Depressive Symptoms: Instrumental-Variable Regression in the Cardiovascular Risk in Young Finns Study.

Authors:  Karolina Wesołowska; Marko Elovainio; Taina Hintsa; Markus Jokela; Laura Pulkki-Råback; Niina Pitkänen; Jari Lipsanen; Janne Tukiainen; Leo-Pekka Lyytikäinen; Terho Lehtimäki; Markus Juonala; Olli Raitakari; Liisa Keltikangas-Järvinen
Journal:  Int J Behav Med       Date:  2017-12

2.  Metabolic syndrome and socioeconomic status in France: The French Nutrition and Health Survey (ENNS, 2006-2007).

Authors:  M Vernay; B Salanave; C de Peretti; C Druet; A Malon; V Deschamps; S Hercberg; K Castetbon
Journal:  Int J Public Health       Date:  2013-09-03       Impact factor: 3.380

Review 3.  Metabolic and neurological complications of second-generation antipsychotic use in children: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Tamara Pringsheim; Darren Lam; Heidi Ching; Scott Patten
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

4.  [Not Available].

Authors:  Tamara Pringsheim; Constadina Panagiotopoulos; Jana Davidson; Josephine Ho
Journal:  Paediatr Child Health       Date:  2012-10       Impact factor: 2.253

5.  High Prevalence of Metabolic Syndrome Among Adolescents and Young Adults With Bipolar Disorder.

Authors:  Christine Li; Boris Birmaher; Brian Rooks; Mary Kay Gill; Heather Hower; David A Axelson; Daniel P Dickstein; Tina R Goldstein; Fangzi Liao; Shirley Yen; Jeffrey Hunt; Satish Iyengar; Neal D Ryan; Michael A Strober; Martin B Keller; Benjamin I Goldstein
Journal:  J Clin Psychiatry       Date:  2019-07-30       Impact factor: 4.384

6.  Positive attributes protect adolescents from risk for the metabolic syndrome.

Authors:  Aimee J Midei; Karen A Matthews
Journal:  J Adolesc Health       Date:  2014-07-22       Impact factor: 5.012

7.  Evidence-based recommendations for monitoring safety of second generation antipsychotics in children and youth.

Authors:  Tamara Pringsheim; Constadina Panagiotopoulos; Jana Davidson; Josephine Ho
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2011-08

8.  Evidence-based recommendations for monitoring safety of second-generation antipsychotics in children and youth.

Authors:  Tamara Pringsheim; Constadina Panagiotopoulos; Jana Davidson; Josephine Ho
Journal:  Paediatr Child Health       Date:  2011-11       Impact factor: 2.253

9.  Concurrent and prospective associations between HPA axis activity and depression symptoms in newlywed women.

Authors:  Fiona Ge; Paula R Pietromonaco; Casey J DeBuse; Sally I Powers; Douglas A Granger
Journal:  Psychoneuroendocrinology       Date:  2016-07-22       Impact factor: 4.905

10.  Disruptions in ovarian function are related to depression and cardiometabolic risk during premenopause.

Authors:  Maria E Bleil; Joyce T Bromberger; Melissa D Latham; Nancy E Adler; Lauri A Pasch; Steven E Gregorich; Mitchell P Rosen; Marcelle I Cedars
Journal:  Menopause       Date:  2013-06       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.